SlideShare ist ein Scribd-Unternehmen logo
1 von 29
INVIVO SCREENING METHODS 
FOR ANTI INFLAMMATORY 
AGENTS 
Presented by 
V.HIMAVALLY 
170213884009 
M.PHARM CHEMISTRY 
Under the guidance: 
Mrs. N.Swathi 
Assist.Proffessor.
INTRODUCTION 
Inflammation is a universal host defense process involving 
a complex network of cell-cell , cell-mediator and tissue 
interraction . It occurs in response to a variety of stimuli 
such as physical, chemical , traumatic and infectious 
agents. 
Apart from exogenous factors, endogenous factors also 
contribute to inflammatory response.
INVIVO SCREENING METHODS FOR ANTI 
INFLAMMATORY AGENTS 
 In this screening methods, the potency of 
antiinflammatory agents are measured, by inducing the 
inflammation in the experimental animal like rats, mice, 
monkeys, dog or either sex can be selected. 
 Before starting any in vivo assays, it is important to 
study the oral acute toxicity study, for the selection of 
test dose. 
 In this maximum tolerated dose and minimum toxic dose 
are calculated, by injecting the test dose at an interval of 
2 hrs in 10, 50,100, 200, 300,... 2000mg/kg pattern.
TYPES OF SCREENING METHODS 
 Based on the symptoms observed during the 
inflammation invivo screening methods for anti 
inflammatory drugs are characterized in to three phases: 
 Acute(or)transient phase: In this phase vasodilation 
and increased capillary permeability are observed. 
 Sub acute phase : Infiltration of leucocytes and 
phagocytes in blood. 
 Chronic inflammatory phase: granuloma formation is 
observed in this phase.
ACUTE PHASE 
 Acute phase: The methods that include acute phase are 
as follows: 
 Carrageenan induced paw oedema in rats 
 Croton-oil induced ear edema 
 Oxazolone induced ear edema 
 U V erythema in guinea pigs 
 Pleurisy in rats 
 Granuloma air pouch technique 
 Vascular permeability
CHRONIC PHASE 
 Chronic phase : The methods that include this chronic 
phase are: 
 Cotton wool granuloma 
 Glass rod granuloma 
 Sponge implantation technique
CARRAGEENAN INDUCED PAW OEDEMA IN 
RATS 
Methodology : 
 Male or female sprague-dawley rats with a body weight 
between 150 and 170g are used . the animals are starved 
for overnight . 
 The animal should be grouped, this grouping is based on 
of test compounds 
 Thirty minutes later, the rats are challenged by a 
subcutaneous injection of 0.05ml of 1% solution of 
carrageenan in to the plantar side of the left hind paw. 
 The paw is marked with ink at the level of lateral 
malleolus and immersed in the mercury up to this mark.
Evaluation: 
 The paw volume was measured using plenthysmometer at 3 
and 6 hr, eventually at 24 hr immediately after the injection. 
 The increase in paw volume at 3 and 6 hr is calculated. 
 The percentage increase in paw volume was measured by 
comparing the difference of the average values between treated 
group animals and control group animals is calculated at each 
interval time. 
 A dose-response curve is run for the active drugs and ED50 
values can be determined. 
 Generally the treated group animal show much less edema than 
control group animal.
CROTON-OIL INDUCED EAR EDEMA IN 
MICE 
Methodology: 
 Both rats and mice are used, usually male rats (sprague-dawley) 
of 80-60kg is selected, where as male swiss mice 
weighing between 18-22g is selected. 
 Grouping is done according to the body weight 
 In this methodology, a total of 15mul containing an acetonic 
solution of 75microg of croton oil is applied to the inner 
surface of the right ear of each mouse. 
 The animals are previously, anaesthetised with diethyl ether at 
a rate 0.02ml in rats and 0.01ml in mice.
Methodology: 
 Left ear remains untreated control group receives the irritant 
solution, while indomethacin serves as a standard (reference). 
 Varying dose levels of test drug are applied to inner surface of 
the right ear of each mouse inducing inflammation. 
 As soon as the test and standard drug are given, the animals are 
sacrificed by cervical dislocation, both treated and untreated 
ear are removed and a plug of 8mm diameter is removed from 
each of the ear. 
 The difference in weight between the two plugs is taken as the 
measure of edematous response
Evaluation: 
 This methodology is mainly used to detect antiinflammatory 
activity of steroids. 
 The % antiinflammatory activity is calculated by, 
% anti inflammatory activity = ( wt of treated ear-wt of 
untreated ear/wt of control ear)*100
OXAZOLONE INDUCED EAR EDEMA IN 
MICE 
 This model permits the quantitative evaluation of the topical 
and systemic antiinflammatory activity of the compound 
following topical administration. 
Methodology: 
 The experimental animal used in this model is mice and they 
are divided into 12 each group. 
 They are injected with the 10ml of 0.5% of oxazolone in 
acetone in to the right ear and the same was given repeatedly 3 
times per week, to the sensitized right ear. 
 In non sensitized animals, acetone alone was given. 
 The mice are again injected with 0.01ml of 2% oxazolone 
solution inside of the right ear, in which test or standard are 
resolved.
 Group of 10 to 15 animals are treated with irritant alone or 
with the solution of the test compound. 
 The left ear remains untreated and actual inflammation occurs 
after 24 hrs. 
 The animals are sacrificed under anaesthesia, at this time and a 
disc of 8mm diameter is punched from both the sides. 
 The discs are allowed to dry and are weighed on a balance. The 
weight difference is an indicator of inflammatory edema. 
Evaluation: 
 Average values of the increase of weight are calculated for each 
treated group and compared statistically with control group.
U V ERYTHEMA IN GUINEA PIGS 
Methodology: 
 Albino guinea pigs of both the sexes weighing about 350g are 
used. 
 Four animals are used each for treatment and the control. 
 18hrs prior to the experiment, the animals are shaved on both 
the flanks and on the back, chemically by means of a depilatory 
cream or using a suspension of barium chloride. 
 The next day the test compound is dissolved in the vehicle and 
half of it is administered to the animal by gavage, 30min before 
the UV exposure.
 Control animals are treated with the vehicle alone. 
 The guinea pigs are placed in a leather cuff with a hole of 
1.5x2.5cm size punched in it, allowing the UV radiation to 
reach only this area. 
 During this time, the remaining half of the test compound is 
administered. 
 Generally the erythema is scored after 2 and 4 hr of exposure. 
Evaluation: 
 The degree of erythema is evaluated in a double blinded 
manner. The following scores are given:
0 – no erythema 
1 – weak erythema 
2 – strong erythema 
4 – very strong erythema 
Animals with a score of 0 or 1 are said to be protected. The 
scoring after 2 and 4hr, generally indicates some duration of the 
effect and ED 
50 
values can be calculated.
PLEURISY TEST 
Methodology: 
 The animal used in pleurisy test was mouse. 
 A single dose of 0.1ml carrageenan was injected intravenously. 
 After 4hr the animal was killed with an over dose of ether and 
the pleural cavity was washed with 1.0ml of sterile PBS, 
containing heparin (20 IU per ml) 
 Samples of the pleural lavage were collected for determination 
of exudation, myeloperoxidase, adenosine de-aminase 
activities, and nitric oxide levels, as well as for determination 
of total and differential leukocyte counts. Total leukocyte 
counts were performed in a Neuberger Chamber.
 The serum level of the C-reactive protein was also analysed. In 
another set of experiment animals were treated 30 min before 
carrageenan with a solution of Evans blue dye (25 mg/kg, i.v.) 
in order to evaluate the degree of exudation in the pleural 
space. 
 The amount of dye was estimated by colorimetry using an Elisa 
plate reader at 600nm, by interpolation from a standard curve 
of Evans blue dye in the range of 0.01 to 50μg/ml. 
Evaluation: 
The values of each experimental group are averaged and 
compared with that control. ED50 values can be calculated using 
various doses.
GRANULOMA POUCH TECHNIQUE 
Methodology: 
 Male or female Sprague-Dawley rats with a body weight 
between 150 and 200g are used. 
 Ten animals are taken for controls and for test groups. 
 The back of the animals is shaved and disinfected. With a very 
thin needle a pneumoderma is made in the middle of the dorsal 
skin by injection of 20ml of air under ether anesthesia, which 
results in oval air pouch. 
 0.5 ml of a 1% solution of Croton oil in sesame oil is injected, 
avoiding any leakage of air. 
 The air pouch is removed after 48hrs.
• The test compound is injected directly in to the air sac at the 
same time as the irritant. 
• On the 4th or 5th day animals are sacrificed under anesthesia. 
• The pouch is opened and the exudate is collected in glass 
cylinders. 
• Total no. of leukocytes migrated in to the pouch are evaluated 
after staining with Erythrosine B. 
Evaluation: 
• The average value of the exudates of the controls and the test 
groups is calculated. 
• Comparison is made by statistical means.
VASCULAR PERMEABILITY 
Methodology: 
 Albino Wistar are used each group containing 4 rats. 
 Control group will receive distilled water 1% w/v 1ml/100g by 
oral route and other group will receive test compound by oral 
route and standard group will receive diclofenac 10ml/kg by 
intraperitoneal route. 
 After 1hr of the administration, rats are injected with 0.25ml of 
0.6% v/v solution of acetic acid intraperitoneally. Immediately, 
10 ml/kg of 10%w/v Evans blue is injected intravenously via 
tail vain.
 After 30 min, the animals are anesthetized with ether 
anesthesia and sacrificed. 
 The abdomen is cut open and exposed viscera. The animals are 
held by a flap of abdominal wall over a Petri dish. 
 The peritoneal fluid (exudates) collected, filtered and made up 
the volume to 10 ml using normal saline solution and 
centrifuged at 3000 rpm for 15 min. The absorbance (A) of the 
supernatant is measured at590 nm using spectrophotometer. 
Evaluation: 
Decreased concentration of dye with respect to absorbance 
indicates reduction in permeability.
COTTON WOOL INDUCED GRANULOMA 
Methodology: 
 Male rats weighing about 180-200g are used. 
 The test drugs were administered orally once on a dosage 
regimen for 7 days and the control group received the vehicle. 
 Two sterilized pellets of cotton wool were implanted 
subcutaneously, one on each side of abdomen of the animal, 
under the light ether anaesthesia and sterile technique. 
 The rats were sacrificed on the 8th day, the implanted pellet was 
dissected out and the wet weight was recorded. Thymuses were 
also dissected out. 
 Both of these were dried at 600 c for 18 hrs and the dry weight 
was recorded.
Evaluation: 
 The weight of transudate and the granuloma as well as the 
percent granuloma inhibition of the test drugs were calculated. 
 The body weight gain was also recorded.
GLASS ROD GRANULOMA TECHNIQUE 
Methodology: 
 In this technique, glass rod with a diameter of 6mm and 
40 mm length are selected. 
 Male sprague-dawley rats with an initial weight of 130g 
are selected. 
 These rats are anaesthetized with ether and their back 
skins were shaved and disinfected. 
 From an incision in the caudal region a subcutaneous 
tunnel is formed in the cranial direction with a closed 
blunted forceps. 
 The glass rod is introduced in to this tunnel which lies on 
the back of the animal.The incision wound is closed by 
sutures.
 The animals are kept in separate cages, the rods remain 
insitu for 20 or 40 days. 
 At the end, the animals are sacrificed under CO2 
anaesthesia. 
 The glass rod is prepared with surrounding connective 
tissue which forms a tube around the glass rod. 
 Wet weight of the granuloma tissue is recorded, finally it 
is dried and the dry weight is also recorded. 
Evaluation: 
 Granuloma weight reduced by the test compound is 
compared with that of the standard.
SPONGE IMPLANTATION TECHNIQUE 
Methodology: 
 Sponges used for implantation are prepared from poly vinyl 
foam sheets (thickness) 5mm discs are punched out to standard 
size and weight(10.0+_0.02mg) using a 13mm cork borer . 
 The sponges are then soaked in 76%v/v ethanol for 30 min, and 
then heated at 800 c for 2 hr. 
 Prior to implantation in the animal, the sponges are soaked in 
sterile 0.9% saline in which either drugs, antigens(or) irritants 
have been suspended. 
 Sponges are implanted in female wistar rats weighing about 
150-200g under ether anaesthesia.
 A 20mm dorsal incision is made and the dermis is separated 
from the underlying muscle layer by insertion of blunt forceps 
to form separate cavities in to which the sponges are inserted. 
 Up to 8 sponges may be implanted per rat .The insertion is 
closed with micheal clips and the animals are maintainted at a 
constant temperature of 240 c. 
Evaluation: 
 For estimation of fluid phase of sponge exudates eg: protein 
content enzyme levels and biological mediators such as 
prostaglandins as well as for leucocyte migration, sponges 
removed after 9 hrs.
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsAnupam dubey
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agentsUttara Joshi
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activitySravanthi Shetty
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methodsShobhiniChandel
 
Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPDJaineel Dharod
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening modelsJaineel Dharod
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDAbdul Hameed
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3pharmacologyseminars
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsAbu Sufiyan Chhipa
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimersDr Roohana Hasan
 
Preclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syedPreclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syedMubasheer syed
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malikVikasMalik68
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsDr. Advaitha MV
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugsKanthlal SK
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugsSrota Dawn
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsHimikaRathi
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsRashmi116
 

Was ist angesagt? (20)

Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
 
screening of antiulcer agents
screening  of antiulcer agentsscreening  of antiulcer agents
screening of antiulcer agents
 
screening methods for Antiepileptic activity
screening methods for Antiepileptic activityscreening methods for Antiepileptic activity
screening methods for Antiepileptic activity
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Screening model for asthma COPD
Screening model for asthma COPDScreening model for asthma COPD
Screening model for asthma COPD
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening models
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3Pharmacological screening of anti arrhythmic drugs 3
Pharmacological screening of anti arrhythmic drugs 3
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugs
 
Screening of anti alzheimers
Screening of anti alzheimersScreening of anti alzheimers
Screening of anti alzheimers
 
Preclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syedPreclinical screening methods of Sedative and hypnotics by syed
Preclinical screening methods of Sedative and hypnotics by syed
 
Screening method of nootropics vikas malik
Screening method of nootropics vikas malikScreening method of nootropics vikas malik
Screening method of nootropics vikas malik
 
Screening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive AgentsScreening Methods of Antihypertensive Agents
Screening Methods of Antihypertensive Agents
 
Anti inflammatory
Anti   inflammatoryAnti   inflammatory
Anti inflammatory
 
Screening of antiepileptic drugs
Screening of antiepileptic drugsScreening of antiepileptic drugs
Screening of antiepileptic drugs
 
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
SCREENING MODELS OF HEPATOPROTECTIVE DRUGS
 
screening of ans drugs
screening of ans drugsscreening of ans drugs
screening of ans drugs
 
Screening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugsScreening models of antiepileptic and nootropic drugs
Screening models of antiepileptic and nootropic drugs
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
 

Andere mochten auch

Evaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsEvaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsDr. Jill Mathew
 
Screening methods for analgesics
Screening methods for analgesicsScreening methods for analgesics
Screening methods for analgesicsDr. Amit Sharma
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugsMy_VivJaan
 
Experimental evaluation of anti inflammatory agents
Experimental evaluation of anti inflammatory agentsExperimental evaluation of anti inflammatory agents
Experimental evaluation of anti inflammatory agentsAditi Panditrao
 
In vivo and in-vitro anti-inflammatory study
In vivo and in-vitro anti-inflammatory studyIn vivo and in-vitro anti-inflammatory study
In vivo and in-vitro anti-inflammatory studyArijit Chakraborty
 
Analgesic screeening model
Analgesic screeening modelAnalgesic screeening model
Analgesic screeening modelChaitra Nagaraj
 

Andere mochten auch (8)

Evaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugsEvaluation of anti inflammatory drugs
Evaluation of anti inflammatory drugs
 
ANALGESIC MODELS
ANALGESIC MODELSANALGESIC MODELS
ANALGESIC MODELS
 
Screening methods for analgesics
Screening methods for analgesicsScreening methods for analgesics
Screening methods for analgesics
 
Screening models for inflammatory drugs
Screening models for inflammatory drugsScreening models for inflammatory drugs
Screening models for inflammatory drugs
 
Experimental evaluation of anti inflammatory agents
Experimental evaluation of anti inflammatory agentsExperimental evaluation of anti inflammatory agents
Experimental evaluation of anti inflammatory agents
 
In vivo and in-vitro anti-inflammatory study
In vivo and in-vitro anti-inflammatory studyIn vivo and in-vitro anti-inflammatory study
In vivo and in-vitro anti-inflammatory study
 
Invivo pharmacology
Invivo pharmacologyInvivo pharmacology
Invivo pharmacology
 
Analgesic screeening model
Analgesic screeening modelAnalgesic screeening model
Analgesic screeening model
 

Ähnlich wie Invivo screening methods for anti inflammatory agents

SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptxSourinDe2
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfVISHALJADHAV100
 
screening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide sharescreening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide shareAnkitha868680
 
Bioassay vasopressin digitalis ACTH
Bioassay vasopressin digitalis ACTHBioassay vasopressin digitalis ACTH
Bioassay vasopressin digitalis ACTHmuthulakshmi623285
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationpradnya Jagtap
 
Screening of anti ulcer agents
Screening of anti ulcer agentsScreening of anti ulcer agents
Screening of anti ulcer agentsDeepmalya Ghosh
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Himanshu Yadav
 
Bioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinHeena Parveen
 
Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agentsChandragiri Siva Sai
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Ch. Bhargava krishna
 
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF ANTI-INF...
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF  ANTI-INF...INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF  ANTI-INF...
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF ANTI-INF...AishaKhan276
 
In vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsIn vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsAdarsh Patil
 
Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology ManjuJhakhar
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerShivam Diwaker
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Dr Ajay Mandal
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for AnalgesicsFoziyaKhan
 
Bioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaBioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaSONALPANDE5
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayHimikaRathi
 

Ähnlich wie Invivo screening methods for anti inflammatory agents (20)

SCREENING OF immuno.pptx
SCREENING OF immuno.pptxSCREENING OF immuno.pptx
SCREENING OF immuno.pptx
 
Inflamation ppt
Inflamation pptInflamation ppt
Inflamation ppt
 
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdfb2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
b2. Bioassay of various endocrine hormones, drugs and autocoids.pdf
 
screening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide sharescreening methods for Antinflammatory drugs slide share
screening methods for Antinflammatory drugs slide share
 
Bioassay vasopressin digitalis ACTH
Bioassay vasopressin digitalis ACTHBioassay vasopressin digitalis ACTH
Bioassay vasopressin digitalis ACTH
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
Anti ulcer
Anti ulcerAnti ulcer
Anti ulcer
 
Screening of anti ulcer agents
Screening of anti ulcer agentsScreening of anti ulcer agents
Screening of anti ulcer agents
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
 
Bioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of Vasopressin
 
Screening models for immunomodulatory agents
Screening models for immunomodulatory agentsScreening models for immunomodulatory agents
Screening models for immunomodulatory agents
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
 
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF ANTI-INF...
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF  ANTI-INF...INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF  ANTI-INF...
INFLAMMATION-A DISCUSSION OF VARIOUS ANIMAL MODELS FOR THE STUDY OF ANTI-INF...
 
In vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agentsIn vivo studies of wound healing and hepatoprotective agents
In vivo studies of wound healing and hepatoprotective agents
 
Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology Respiratory and reproduction pharmacology
Respiratory and reproduction pharmacology
 
Screening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwakerScreening methods of immunomodulators by shivam diwaker
Screening methods of immunomodulators by shivam diwaker
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
 
Screening methods for Analgesics
Screening methods for AnalgesicsScreening methods for Analgesics
Screening methods for Analgesics
 
Bioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaBioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeia
 
Antiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assayAntiallergic activity by mast cell stabilization assay
Antiallergic activity by mast cell stabilization assay
 

Mehr von Sravani Ganti

hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetate
hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetatehetreocyclic applications of ethyl aceto acetate & ethyl cyano acetate
hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetateSravani Ganti
 
Antihypertensive agents. calcium channel blockers
Antihypertensive agents. calcium channel blockersAntihypertensive agents. calcium channel blockers
Antihypertensive agents. calcium channel blockersSravani Ganti
 
ion exchange and gel permetion chromatography
ion exchange and gel permetion chromatographyion exchange and gel permetion chromatography
ion exchange and gel permetion chromatographySravani Ganti
 
High performance thin layer chromatography
High performance thin layer chromatographyHigh performance thin layer chromatography
High performance thin layer chromatographySravani Ganti
 

Mehr von Sravani Ganti (6)

Anova ppt
Anova pptAnova ppt
Anova ppt
 
hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetate
hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetatehetreocyclic applications of ethyl aceto acetate & ethyl cyano acetate
hetreocyclic applications of ethyl aceto acetate & ethyl cyano acetate
 
Antihypertensive agents. calcium channel blockers
Antihypertensive agents. calcium channel blockersAntihypertensive agents. calcium channel blockers
Antihypertensive agents. calcium channel blockers
 
GAS CHROMATOGRAPHY
GAS CHROMATOGRAPHYGAS CHROMATOGRAPHY
GAS CHROMATOGRAPHY
 
ion exchange and gel permetion chromatography
ion exchange and gel permetion chromatographyion exchange and gel permetion chromatography
ion exchange and gel permetion chromatography
 
High performance thin layer chromatography
High performance thin layer chromatographyHigh performance thin layer chromatography
High performance thin layer chromatography
 

Kürzlich hochgeladen

Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 

Kürzlich hochgeladen (20)

Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 

Invivo screening methods for anti inflammatory agents

  • 1. INVIVO SCREENING METHODS FOR ANTI INFLAMMATORY AGENTS Presented by V.HIMAVALLY 170213884009 M.PHARM CHEMISTRY Under the guidance: Mrs. N.Swathi Assist.Proffessor.
  • 2. INTRODUCTION Inflammation is a universal host defense process involving a complex network of cell-cell , cell-mediator and tissue interraction . It occurs in response to a variety of stimuli such as physical, chemical , traumatic and infectious agents. Apart from exogenous factors, endogenous factors also contribute to inflammatory response.
  • 3. INVIVO SCREENING METHODS FOR ANTI INFLAMMATORY AGENTS  In this screening methods, the potency of antiinflammatory agents are measured, by inducing the inflammation in the experimental animal like rats, mice, monkeys, dog or either sex can be selected.  Before starting any in vivo assays, it is important to study the oral acute toxicity study, for the selection of test dose.  In this maximum tolerated dose and minimum toxic dose are calculated, by injecting the test dose at an interval of 2 hrs in 10, 50,100, 200, 300,... 2000mg/kg pattern.
  • 4. TYPES OF SCREENING METHODS  Based on the symptoms observed during the inflammation invivo screening methods for anti inflammatory drugs are characterized in to three phases:  Acute(or)transient phase: In this phase vasodilation and increased capillary permeability are observed.  Sub acute phase : Infiltration of leucocytes and phagocytes in blood.  Chronic inflammatory phase: granuloma formation is observed in this phase.
  • 5. ACUTE PHASE  Acute phase: The methods that include acute phase are as follows:  Carrageenan induced paw oedema in rats  Croton-oil induced ear edema  Oxazolone induced ear edema  U V erythema in guinea pigs  Pleurisy in rats  Granuloma air pouch technique  Vascular permeability
  • 6. CHRONIC PHASE  Chronic phase : The methods that include this chronic phase are:  Cotton wool granuloma  Glass rod granuloma  Sponge implantation technique
  • 7. CARRAGEENAN INDUCED PAW OEDEMA IN RATS Methodology :  Male or female sprague-dawley rats with a body weight between 150 and 170g are used . the animals are starved for overnight .  The animal should be grouped, this grouping is based on of test compounds  Thirty minutes later, the rats are challenged by a subcutaneous injection of 0.05ml of 1% solution of carrageenan in to the plantar side of the left hind paw.  The paw is marked with ink at the level of lateral malleolus and immersed in the mercury up to this mark.
  • 8. Evaluation:  The paw volume was measured using plenthysmometer at 3 and 6 hr, eventually at 24 hr immediately after the injection.  The increase in paw volume at 3 and 6 hr is calculated.  The percentage increase in paw volume was measured by comparing the difference of the average values between treated group animals and control group animals is calculated at each interval time.  A dose-response curve is run for the active drugs and ED50 values can be determined.  Generally the treated group animal show much less edema than control group animal.
  • 9. CROTON-OIL INDUCED EAR EDEMA IN MICE Methodology:  Both rats and mice are used, usually male rats (sprague-dawley) of 80-60kg is selected, where as male swiss mice weighing between 18-22g is selected.  Grouping is done according to the body weight  In this methodology, a total of 15mul containing an acetonic solution of 75microg of croton oil is applied to the inner surface of the right ear of each mouse.  The animals are previously, anaesthetised with diethyl ether at a rate 0.02ml in rats and 0.01ml in mice.
  • 10. Methodology:  Left ear remains untreated control group receives the irritant solution, while indomethacin serves as a standard (reference).  Varying dose levels of test drug are applied to inner surface of the right ear of each mouse inducing inflammation.  As soon as the test and standard drug are given, the animals are sacrificed by cervical dislocation, both treated and untreated ear are removed and a plug of 8mm diameter is removed from each of the ear.  The difference in weight between the two plugs is taken as the measure of edematous response
  • 11. Evaluation:  This methodology is mainly used to detect antiinflammatory activity of steroids.  The % antiinflammatory activity is calculated by, % anti inflammatory activity = ( wt of treated ear-wt of untreated ear/wt of control ear)*100
  • 12. OXAZOLONE INDUCED EAR EDEMA IN MICE  This model permits the quantitative evaluation of the topical and systemic antiinflammatory activity of the compound following topical administration. Methodology:  The experimental animal used in this model is mice and they are divided into 12 each group.  They are injected with the 10ml of 0.5% of oxazolone in acetone in to the right ear and the same was given repeatedly 3 times per week, to the sensitized right ear.  In non sensitized animals, acetone alone was given.  The mice are again injected with 0.01ml of 2% oxazolone solution inside of the right ear, in which test or standard are resolved.
  • 13.  Group of 10 to 15 animals are treated with irritant alone or with the solution of the test compound.  The left ear remains untreated and actual inflammation occurs after 24 hrs.  The animals are sacrificed under anaesthesia, at this time and a disc of 8mm diameter is punched from both the sides.  The discs are allowed to dry and are weighed on a balance. The weight difference is an indicator of inflammatory edema. Evaluation:  Average values of the increase of weight are calculated for each treated group and compared statistically with control group.
  • 14. U V ERYTHEMA IN GUINEA PIGS Methodology:  Albino guinea pigs of both the sexes weighing about 350g are used.  Four animals are used each for treatment and the control.  18hrs prior to the experiment, the animals are shaved on both the flanks and on the back, chemically by means of a depilatory cream or using a suspension of barium chloride.  The next day the test compound is dissolved in the vehicle and half of it is administered to the animal by gavage, 30min before the UV exposure.
  • 15.  Control animals are treated with the vehicle alone.  The guinea pigs are placed in a leather cuff with a hole of 1.5x2.5cm size punched in it, allowing the UV radiation to reach only this area.  During this time, the remaining half of the test compound is administered.  Generally the erythema is scored after 2 and 4 hr of exposure. Evaluation:  The degree of erythema is evaluated in a double blinded manner. The following scores are given:
  • 16. 0 – no erythema 1 – weak erythema 2 – strong erythema 4 – very strong erythema Animals with a score of 0 or 1 are said to be protected. The scoring after 2 and 4hr, generally indicates some duration of the effect and ED 50 values can be calculated.
  • 17. PLEURISY TEST Methodology:  The animal used in pleurisy test was mouse.  A single dose of 0.1ml carrageenan was injected intravenously.  After 4hr the animal was killed with an over dose of ether and the pleural cavity was washed with 1.0ml of sterile PBS, containing heparin (20 IU per ml)  Samples of the pleural lavage were collected for determination of exudation, myeloperoxidase, adenosine de-aminase activities, and nitric oxide levels, as well as for determination of total and differential leukocyte counts. Total leukocyte counts were performed in a Neuberger Chamber.
  • 18.  The serum level of the C-reactive protein was also analysed. In another set of experiment animals were treated 30 min before carrageenan with a solution of Evans blue dye (25 mg/kg, i.v.) in order to evaluate the degree of exudation in the pleural space.  The amount of dye was estimated by colorimetry using an Elisa plate reader at 600nm, by interpolation from a standard curve of Evans blue dye in the range of 0.01 to 50μg/ml. Evaluation: The values of each experimental group are averaged and compared with that control. ED50 values can be calculated using various doses.
  • 19. GRANULOMA POUCH TECHNIQUE Methodology:  Male or female Sprague-Dawley rats with a body weight between 150 and 200g are used.  Ten animals are taken for controls and for test groups.  The back of the animals is shaved and disinfected. With a very thin needle a pneumoderma is made in the middle of the dorsal skin by injection of 20ml of air under ether anesthesia, which results in oval air pouch.  0.5 ml of a 1% solution of Croton oil in sesame oil is injected, avoiding any leakage of air.  The air pouch is removed after 48hrs.
  • 20. • The test compound is injected directly in to the air sac at the same time as the irritant. • On the 4th or 5th day animals are sacrificed under anesthesia. • The pouch is opened and the exudate is collected in glass cylinders. • Total no. of leukocytes migrated in to the pouch are evaluated after staining with Erythrosine B. Evaluation: • The average value of the exudates of the controls and the test groups is calculated. • Comparison is made by statistical means.
  • 21. VASCULAR PERMEABILITY Methodology:  Albino Wistar are used each group containing 4 rats.  Control group will receive distilled water 1% w/v 1ml/100g by oral route and other group will receive test compound by oral route and standard group will receive diclofenac 10ml/kg by intraperitoneal route.  After 1hr of the administration, rats are injected with 0.25ml of 0.6% v/v solution of acetic acid intraperitoneally. Immediately, 10 ml/kg of 10%w/v Evans blue is injected intravenously via tail vain.
  • 22.  After 30 min, the animals are anesthetized with ether anesthesia and sacrificed.  The abdomen is cut open and exposed viscera. The animals are held by a flap of abdominal wall over a Petri dish.  The peritoneal fluid (exudates) collected, filtered and made up the volume to 10 ml using normal saline solution and centrifuged at 3000 rpm for 15 min. The absorbance (A) of the supernatant is measured at590 nm using spectrophotometer. Evaluation: Decreased concentration of dye with respect to absorbance indicates reduction in permeability.
  • 23. COTTON WOOL INDUCED GRANULOMA Methodology:  Male rats weighing about 180-200g are used.  The test drugs were administered orally once on a dosage regimen for 7 days and the control group received the vehicle.  Two sterilized pellets of cotton wool were implanted subcutaneously, one on each side of abdomen of the animal, under the light ether anaesthesia and sterile technique.  The rats were sacrificed on the 8th day, the implanted pellet was dissected out and the wet weight was recorded. Thymuses were also dissected out.  Both of these were dried at 600 c for 18 hrs and the dry weight was recorded.
  • 24. Evaluation:  The weight of transudate and the granuloma as well as the percent granuloma inhibition of the test drugs were calculated.  The body weight gain was also recorded.
  • 25. GLASS ROD GRANULOMA TECHNIQUE Methodology:  In this technique, glass rod with a diameter of 6mm and 40 mm length are selected.  Male sprague-dawley rats with an initial weight of 130g are selected.  These rats are anaesthetized with ether and their back skins were shaved and disinfected.  From an incision in the caudal region a subcutaneous tunnel is formed in the cranial direction with a closed blunted forceps.  The glass rod is introduced in to this tunnel which lies on the back of the animal.The incision wound is closed by sutures.
  • 26.  The animals are kept in separate cages, the rods remain insitu for 20 or 40 days.  At the end, the animals are sacrificed under CO2 anaesthesia.  The glass rod is prepared with surrounding connective tissue which forms a tube around the glass rod.  Wet weight of the granuloma tissue is recorded, finally it is dried and the dry weight is also recorded. Evaluation:  Granuloma weight reduced by the test compound is compared with that of the standard.
  • 27. SPONGE IMPLANTATION TECHNIQUE Methodology:  Sponges used for implantation are prepared from poly vinyl foam sheets (thickness) 5mm discs are punched out to standard size and weight(10.0+_0.02mg) using a 13mm cork borer .  The sponges are then soaked in 76%v/v ethanol for 30 min, and then heated at 800 c for 2 hr.  Prior to implantation in the animal, the sponges are soaked in sterile 0.9% saline in which either drugs, antigens(or) irritants have been suspended.  Sponges are implanted in female wistar rats weighing about 150-200g under ether anaesthesia.
  • 28.  A 20mm dorsal incision is made and the dermis is separated from the underlying muscle layer by insertion of blunt forceps to form separate cavities in to which the sponges are inserted.  Up to 8 sponges may be implanted per rat .The insertion is closed with micheal clips and the animals are maintainted at a constant temperature of 240 c. Evaluation:  For estimation of fluid phase of sponge exudates eg: protein content enzyme levels and biological mediators such as prostaglandins as well as for leucocyte migration, sponges removed after 9 hrs.